Welcome to LookChem.com Sign In|Join Free

CAS

  • or

67580-08-9

Post Buying Request

67580-08-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

67580-08-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 67580-08-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,5,8 and 0 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 67580-08:
(7*6)+(6*7)+(5*5)+(4*8)+(3*0)+(2*0)+(1*8)=149
149 % 10 = 9
So 67580-08-9 is a valid CAS Registry Number.

67580-08-9Relevant articles and documents

A new nontricyclic antidepressant agent. Synthesis and activity of N-[trans-2-(dimethylamino)cyclopentyl]-N-(3,4-dichlorphenyl)propanamide and related compounds

Szmuszkovicz,Von Voigtlander,Kane

, p. 1230 - 1236 (2007/10/02)

A series of new nontricyclic antidepressant compounds was synthesized. A representative of this class is shown. Five structural parameters were investigated: ring size, cis/trans stereochemistry, amide substitution, aromatic substitution, and amine substi

N-(2-aminocycloheptyl)alkanoylanilides

-

, (2008/06/13)

N-(2-aminocycloheptyl)N-alkanoylanilides and their 2-N-oxides of the formula STR1 e.g., trans-3,4-dichloro-N-[2-(allylamino)cycloheptyl]propionanilide, and their pharmacologically acceptable salts, have been found to possess potent Central Nervous System

N-(2-aminocycloheptyl)alkanoylanilides and in the treatment of depression

-

, (2008/06/13)

N-(2-aminocycloheptyl)N-alkanoylanilides and their 2-N-oxides of the formula STR1 e.g., trans-3,4-dichloro-N-[2-(dimethylamino)cycloheptyl]propionanilide, and their pharmacologically acceptable salts, have been found to possess potent Central Nervous System antidepressant properties. Many of them are new. These compounds are promising antidepressant drugs which are characterized by lower toxicity than imipramine, and long acting activity which may allow longer durations between administrations, e.g., once a day. Pharmaceutical compositions containing these compounds and a process for treating conditions of depression with these compositions are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 67580-08-9